TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $3.39 million. The enterprise value is -$6.81 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TNFA has 2.76 million shares outstanding. The number of shares has increased by 52.29% in one year.
Current Share Class | 2.76M |
Shares Outstanding | 2.76M |
Shares Change (YoY) | +52.29% |
Shares Change (QoQ) | +6.13% |
Owned by Insiders (%) | 3.01% |
Owned by Institutions (%) | 1.79% |
Float | 2.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.18 |
P/TBV Ratio | 0.55 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.00.
Current Ratio | 1.72 |
Quick Ratio | 1.52 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -142.68% and return on invested capital (ROIC) is -42.75%.
Return on Equity (ROE) | -142.68% |
Return on Assets (ROA) | -31.01% |
Return on Capital (ROIC) | -42.75% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.82M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.86% in the last 52 weeks. The beta is 2.67, so TNFA's price volatility has been higher than the market average.
Beta (5Y) | 2.67 |
52-Week Price Change | -85.86% |
50-Day Moving Average | 1.46 |
200-Day Moving Average | 2.14 |
Relative Strength Index (RSI) | 40.70 |
Average Volume (20 Days) | 30,109 |
Short Selling Information
The latest short interest is 267,349, so 9.70% of the outstanding shares have been sold short.
Short Interest | 267,349 |
Short Previous Month | 252,883 |
Short % of Shares Out | 9.70% |
Short % of Float | 13.36% |
Short Ratio (days to cover) | 4.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.38M |
Pretax Income | -12.29M |
Net Income | -28.92M |
EBITDA | n/a |
EBIT | -11.38M |
Earnings Per Share (EPS) | -$13.34 |
Full Income Statement Balance Sheet
The company has $10.64 million in cash and $18,285 in debt, giving a net cash position of $10.62 million or $3.86 per share.
Cash & Cash Equivalents | 10.64M |
Total Debt | 18,285 |
Net Cash | 10.62M |
Net Cash Per Share | $3.86 |
Equity (Book Value) | 17.06M |
Book Value Per Share | 6.73 |
Working Capital | 5.04M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -10.14M |
Capital Expenditures | n/a |
Free Cash Flow | -10.14M |
FCF Per Share | -$3.68 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |